Moffitt Researchers Discover New Therapeutic Target for Non-Small Cell Lung Cancer
Newswise — TAMPA, Fla. — Non-small cell lung cancer accounts for nearly 85% of all lung cancer cases. Targeted immunotherapy is a common treatment, but it does not work for everyone. However, a new Moffitt Cancer Center study published in the journal …